Israel and Australia’s Partnership for a Cause
Diabetes has become a crippling problem for the pacific Islands, which has recorded one of the highest rates of the disease in the world (Israel in Focus)
Supporting children and young people with diabetes: guidance for nurses in schools and early years settings
This publication aims to ensure that children and young people with diabetes receive appropriate care without prejudicing their health or education. 14-page PDF (RCN, UK)
Initial insulin therapy in children and adolescents with type 1 diabetes mellitus
The predictive factors of insulin requirement may exert beneficial effects on the assessment and adjustment of insulin therapy in young diabetic subjects at disease onset. On the basis of a multiple, linear regression, we suggest a formula to calculate the initial insulin therapy (Pediatric Diabetes)
Child obesity drug use ‘soaring’
The number of under-18s in the UK being prescribed weight-loss drugs rose 15-fold between 1999 and 2006, a study of data from GPs suggests (BBC, UK)
Stomach stapling and diabetes
This does not mean that weight-loss surgery is the solution to diabetes. Bariatric surgery is only ever performed as a last resort in morbidly obese people who fulfil the following strict criteria as defined by NICE (NHS Choices, UK)
Low-Fat versus Low-Carbohydrate Weight Reduction Diets: Effects on Weight Loss, Insulin Resistance and Cardiovascular Risk A Randomised Control Trial
This study demonstrates comparable effects on insulin resistance of low-fat and low-carbohydrate diets independent of macronutrient content. The difference in augmentation index may imply a negative effect of low-carbohydrate diets on vascular risk (Diabetes)
4 year follow-up of Diamyd® Phase II study shows clear positive trend
Diamyd Medical announced today that the company’s 4-year follow-up of type 1 diabetes patients included in the company’s Phase II study shows a clear positive trend (Diamyd Medical)
Hikma boosted by diabetes medicines
Increasingly westernised lifestyles amongst people in the Middle East have boosted profits at Hikma Pharmaceuticals amidst higher margins and increased sales of hypertension and diabetes drugs (Financial Times, UK)
Big stage for diabetes hopeful
Recent regulatory setbacks aside, Takeda Pharmaceutical Co. is plowing full steam ahead on its quest to win approval for the company’s key type 2 diabetes drug alogliptin, another potential entrant into the suddenly competitive field of DPP-4 inhibitors (PharmaLive)
Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin
The U.S. Food and Drug Administration has agreed to the study design for a cardiovascular outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) foralogliptin (PharmaLive)
New service to link people with type 1 to clinical trials
This online service is designed to help people with type 1 and their families better understand the clinical trial landscape. We also want to give you the information you need to make a decision about taking an active role in the search for the cure (JDRF)
New Diabetes Device May Be Next Step in Quest for Artificial Pancreas
This new device, now available in more than 50 countries outside of the United States, can automatically suspend insulin delivery when the device senses that glucose levels have fallen to or below a user-selected threshold (Business Wire)
Diabetes UK Chief Medical Advisor appointed
Dr Brian Karet has been appointed Diabetes UK Chief Medical Advisor (Primary Care), a newly-created position jointly sponsored by Diabetes UK and the Royal College of General Practitioners (Diabetes, UK)
GI News
September 2009
Glycosmedia is also available as an App:
